2019
LANCET INFECTIOUS DISEASES, (2019).19 7 10.1016/S1473-3099(19)30126-4.
2019
Clinical microbiology and infection, (2019).26 3 10.1016/j.cmi.2019.06.029.
Mathematical modelling of the epidemiological impact, budget impact and cost-effectiveness of novel tuberculosis vaccines on multidrug-resistant tuberculosis [Oral Presentation].
2019
International Journal of Tuberculosis and Lung Disease, (2019).23 10
2019
HUMAN VACCINES & IMMUNOTHERAPEUTICS, (2019).15 5 10.1080/21645515.2019.1586031.
2019
Vaccine, (2019).37 23 10.1016/j.vaccine.2019.04.058.
2019
FRONTIERS IN IMMUNOLOGY, (2019).10 JUL 10.3389/fimmu.2019.01344.
How might novel vaccines for prevention of Tuberculosis disease impact multi-drug resistant tuberculosis burden? A mathematical modelling-based analysis of epidemiologic and health economic impact.
2019
(2019).
2019
BMC PUBLIC HEALTH, (2019).19 1 10.1186/s12889-019-6655-y.
2019
Journal of The Royal Society Interface, (2019).16 157 10.1098/rsif.2019.0234.
2019
, London School of Hygiene & Tropical Medicine (2019). 10.17037/PUBS.04655690.